Clinical usefulness of 99m Tc-EDDA/HYNIC-TOC scintigraphy in oncological diagnostics: a preliminary communication
- 5 July 2003
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 30 (10), 1402-1406
- https://doi.org/10.1007/s00259-003-1254-6
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Somatostatin receptor imagingSeminars in Nuclear Medicine, 2002
- Somatostatin receptor sst1–sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligandsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2001
- [123I]Metaiodobenzylguanidine and[111In]Octreotide Uptake in Benign and Malignant Pheochromocytomas1Journal of Clinical Endocrinology & Metabolism, 2001
- 99mTc-EDDA/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours; first clinical results and intra-patient comparison with 111In-labelled octreotide derivatives.European Journal of Nuclear Medicine and Molecular Imaging, 2000
- Preclinical evaluation of technetium-99m-labeled somatostatin receptor-binding peptides.1996
- The value of octreotide scintigraphy in patients with lung cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 1994
- Sensitivity versus specificity in melanoma imaging using iodine-123 iodobenzamide and indium-111 pentetreotideEuropean Journal of Nuclear Medicine and Molecular Imaging, 1994
- Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1993
- Identification of somatostatin receptors in human small cell lung carcinomaCancer, 1990
- Somatostatin receptors are present in small‐cell but not in non‐small‐cell primary lung carcinomas: Relationship to EGF‐receptorsInternational Journal of Cancer, 1990